Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
04:00pm, Monday, 01'st Jun 2026
GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Tuesday, 26'th May 2026
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
10:20pm, Wednesday, 13'th May 2026
Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
01:15pm, Wednesday, 13'th May 2026
The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking the potential winners in the hantavirus vaccine market would hardly be worth the time and risk.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:01am, Tuesday, 12'th May 2026
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
10:53am, Monday, 11'th May 2026
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday's close of $54.35.
Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb
09:29am, Monday, 11'th May 2026
Moderna Inc. (NASDAQ:MRNA) and Novavax Inc. (NASDAQ:NVAX) shares moved higher Monday as traders piled back into vaccine names following renewed concerns over a hantavirus outbreak tied to the MV Hondi
Hantavirus cases spark surge in pharma and biotech stocks — here's why
07:53am, Monday, 11'th May 2026
Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak. Moderna, Inovio, Novavax, and Emergent Biosolutions rose in early market trading.
What's Going On With Novavax Stock On Friday?
02:18pm, Friday, 08'th May 2026
Novavax Inc. (NASDAQ:NVAX) stock is trading higher on Friday in reaction to a surge in Moderna Inc. (NASDAQ:MRNA).
Novavax to Participate in BofA Securities 2026 Health Care Conference
04:00pm, Thursday, 07'th May 2026
GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.
NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum
12:16pm, Thursday, 07'th May 2026
Novavax's shares rise 16% after Q1 earnings beat estimates as the company expands Matrix-M partnerships across oncology and infectious diseases.
Why Novavax Stock Is Trading Higher On Wednesday?
03:07pm, Wednesday, 06'th May 2026
Novavax Inc. (NASDAQ:NVAX) shares are trading higher on Wednesday after the company reported better-than-expected first-quarter financial results.
Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript
02:21pm, Wednesday, 06'th May 2026
Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript
Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates
10:30am, Wednesday, 06'th May 2026
Novavax (NVAX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to earnings of $2.93 per share a year ago.
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
08:00am, Wednesday, 06'th May 2026
Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M ® in two infectious disease areas In April,
